News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Plant-Based Biologics All the Rage as Lumen Partners with Google
In a partnership with Google, Seattle-based company Lumen BioScience can now use machine learning as a tool to expedite and streamline production of its plant-based
Seagen Strikes $2.6 Billion ADC Deal with China’s RemeGen
Last week, Seagen, a Washington-based biotech company, announced a deal with China-based RemeGen Co., Ltd. The deal, valued at $2.6 billion, allows Seagen to develop
In Washington’s life sciences sector, a streak of companies going public
Washington’s life science industry is thriving. In 2021 so far, almost 50 biotech companies have gone public across the U.S., with several headquartered in the
Life Science Washington CEO plans to retire at year’s end
This week, Life Science Washington announced its president and CEO, Dr. Leslie Alexandre, will retire at the end of 2021. “Dr. Alexandre has been instrumental
‘We’ve been instrumental’: How Seattle became a hub for COVID-19 vaccine research
Several Seattle-area vaccine scientists shifted their studies to focus on COVID-19 research in the past 18 months. This field of study continues to build on
Icosavax stock skyrockets 200% on first day of trading for newly public Seattle biotech company
Icosavax stocks are performing well amidst the Seattle-based companies new public offering. On its first day as a publicly traded company, Icosavax shares skyrocketed by